Larimar Therapeutics LRMR
NASDAQ LRMR
$2.42 -0.02 (-0.82%)
At close: Oct 21, 2026 · 4:00 PM EDT

Larimar Therapeutics (LRMR) Preferred Dividend Payments (2013 - 2014)

Updated

Larimar Therapeutics' Preferred Dividend Payments was $92,000 in FY2014, down 56.8% from $213,000 in FY2013.

Analysis

Larimar Therapeutics (LRMR) Preferred Dividend Payments (2013 - 2014) Analysis & Trends

  • Per Business Quant data, Preferred Dividend Payments in earlier years was $213,000 in FY2013 (+217.9%) and $67,000 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Larimar Therapeutics 252.95 Mn -354.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 43,000.00
Mar 31, 2014 49,000.00
Dec 31, 2013 53,000.00
Sep 30, 2013 53,000.00
Jun 30, 2013 54,000.00
API Access

Larimar Therapeutics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=LRMR&period=max&api_key=YOUR_API_KEY